Latest News

Clues beginning to emerge on asymtomatic SARS-CoV-2 infection
Back in November of 2020, during the first wave of the COVID-19 pandemic, I was teaching an in-person microbiology laboratory. One of my students had just been home to see his parents, and they all c…
Read more
Could there maybe be better uses of genetics and probiotics?
Professor Meng Dong and his laboratory have created a probiotic that can metabolize alcohol quickly and maybe prevent some of the adverse effects of alcohol consumption. The scientists cloned a highl…
Read more
ChatGPT is not the end of essays in education
The takeover of AI is upon us! AI can now take all our jobs, is the click-bait premise you hear from the news. While I cannot predict the future, I am dubious that AI will play such a dubious role in…
Read more
Fighting infections with infections
Multi-drug-resistant bacterial infections are becoming more of an issue, with 1.2 million people dying of previously treatable bacterial infections. Scientists are frantically searching for new metho…
Read more
A tale of two colleges
COVID-19 at the University of Wisconsin this fall has been pretty much a non-issue. While we are wearing masks, full in-person teaching is happening on campus. Bars, restaurants, and all other busine…
Read more

News

Predatory Bacteria and Human Health


 

There are many example strains of pathogenic bacteria that have developed resistant to drugs. The reduced effectiveness of antibiotic drugs for treating infections is increasingly a concern for doctors and patients alike. Pneumonia is caused by a microbial infection of the lungs, and if untreated it can be painful and fatal. Traditionally pneumonia is treated by using antibiotic drugs to combat the infecting microbes. However, Klebsiella pneumoniae is one example of a drug resistant bacteria that causes pneumonia when it infects the lungs. Treating such an infection is very difficult if antibiotics are not effective. Researchers are looking for alternatives to antibiotic drugs to combat pathogenic infections.

 

One alternative that is being studied is the use of predatory bacteria. Predatory bacteria make a living by “eating” other bacteria. The idea is to let predatory bacteria do what they do best, but for us, by introducing them into tissues that are already infected with bacteria. Once established the predatory bacteria will begin consuming the infectious bacteria. This could be an effective alternative to treat some types infections caused by drug resistant bacteria. Micavibrio aeruginosavorus is a predatory bacteria that attaches and sucks the insides of it’s bacterial prey. It is unlikely that any drug resistant bacteria will also become resistant to this “vampire” bacteria.

Currently studies are being done to first see if these predatory bacteria will be safe to use in humans. Additionally researchers are testing if these bacteria will be effective predators for a variety of drug resistant bacteria. The initial studies are promising. However, using them in humans is complicated by our immune systems, which may see the predatory bacteria as just another foreign body to combat and not as a helpful ally. It is unlike that predatory will be magic bullet for all drug resistant infections, but they might be suited well to topical applications such as burns.


If using predatory bacteria to treat infections seems like a far fetched idea consider the fact that bacteria already play a critical role in human health. Our body’s natural flora of bacteria, called the human microbiota, are vital to our immune systems by producing antibiotics that target foreign bacteria and by simply taking up space. The roles our bacterial residences fill are not all that dissimilar to the roles predatory bacteria could potentially provide.